April XX, 2012, Carmichael, CA — Tamara Navarro, Ph.D., a leading author and trainer to support people with mental illness, is receiving a prestigious Reintegration Award during the 42nd National Council Mental Health and Addictions Conference April 15-17 in Chicago. SARDAA nominated Dr. Navarro for her work as an SA leader and member of SARDAA’s speakers bureau.
Dr. Tamara Navarro has pushed herself through school and runs a private practice helping those with Schizophrenia and their families. She’s been a Schizophrenics Anonymous Leader and a speaker in national conferences. Dr. Navarro also provides support to people with schizophrenia internationally. She’s been consistently honored for her work as a leader including being named Supervisor of the Year at her work. She was also awarded the Self-Help Award of the Year by Yolo County Mental Health Association and the Above & Beyond award from Schizophrenics Anonymous. She’s written articles about her disease and recovery and is working on a book. At the time Dr. Navarro was accepting her award she learned that The Food and Drug Administration has hired her to act as a special consultant representing patients who suffer from schizophrenia and related disorders for the Psychopharmacologic Drug Advisory Committee.
Schizophrenia and Related Diseases Alliance of America (SARDAA) is an organization dedicated to the support of persons who live with schizophrenia and related disorders. SARDAA has been organized to continue ongoing support for Schizophrenics Anonymous, create a national toll-free hotline, provide information on its website, promote personal stories of recovery and hope, organize a speaker’s bureau of people with expertise about living with the disease, family issues and support for care professionals. Their focus is on providing materials and information that will assist people in their own personal journey in living with their illness.
“Armed with the knowledge and experience of her own uphill battle with Schizophrenia, Dr. Navarro has had a tremendous impact on those struggling with their own mental illness. She is living proof that ongoing recovery from mental illness is possible,” said Linda Rosenberg, President and CEO of the National Council for Community Behavioral Healthcare (National Council).
An estimated one in five Americans ages 18 and older suffers from a diagnosable mental disorder every year. The World Health Organization has reported that four of the 10 leading causes of disability in the U.S. and other developed countries are mental disorders.
An independent panel of mental health leaders chose the award winners. First place honorees receive a $10,000 donation, supported by Eli Lilly and Company, to donate to the organization of their choice.
“As a speaker, trainer and author, she is a powerful voice speaking up for the rights of some of society’s most vulnerable people,” said Lilly quote. “She serves as an example of how one passionate person can make a positive difference in the lives of so many others.”
Honorees of the 2012 Reintegration Awards are being recognized at an awards ceremony on April 16 as part of the National Council Conference in Chicago.
About the Reintegration Awards
Since 1997, the Reintegration Awards, supported by Eli Lilly and Company, have celebrated the achievements of those in the community who dedicate themselves to improving the lives of individuals with serious mental illnesses, and the achievements of those living with schizophrenia or bipolar disorder who battle tremendous odds to improve their own lives and the lives of their peers. In 2012, the National Council for Community Behavioral Healthcare is proud to partner with Lilly to offer the Reintegration Awards.
About the National Council for Community Behavioral Healthcare
The National Council for Community Behavioral Healthcare is a not-for-profit, 501(c)(3) association of 1,950 community healthcare organizations that provide treatment and rehabilitation for mental illnesses and addiction disorders to nearly 6 million adults, children and families in communities across the country.
About Eli Lilly and Company
Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers — through medicines and information — for some of the world’s most urgent medical needs. Additional information about Lilly is available at www.lilly.com; Lilly’s clinical trial registry is available at www.lillytrials.com.
For press passes to the awards ceremony or to speak to the winners, contact:
Mike Weaver at MikeW@thenationalcouncil.org or 202.684.7457, ext. 244
Keri McGrath-Happe at MCGRATH_HAPPE_KERI_S@LILLY.COM or 317.370.8394